Ohcanbohtosat - Michael S. Vincent

Safety and Efficacy of Ritlecitinib and Brepocitinib in Alopecia Areata: Results from the Crossover Open-Label Extension of the ALLEGRO Phase 2a Trial Dahkki Brett King, Emma Guttman-Yassky, Elena Peeva, Anindita Banerjee, Linda Zhu, Hua Zhu, Lori Ann Cox, Michael S. Vincent, Rodney Sinclair

Connect to this object online.

Safety and Pharmacokinetics of the Oral TYK2 Inhibitor PF‐06826647: A Phase I, Randomized, Double‐Blind, Placebo‐Controlled, Dose‐Escalation Study Dahkki Ravi Shankar P. Singh, Vivek Pradhan, Erika S. Roberts, Matthew Scaramozza, Elizabeth Kieras, Jeremy D. Gale, Elena Peeva, Michael S. Vincent, Anindita Banerjee, Andrew Fensome, Martin E. Dowty, Peter Winkle, Christopher Tehlirian

Connect to this object online.